Progress in the curative treatment of childhood hematologic malignancies

Journal of the National Cancer Institute

Volumn 100, Issue 18, 2008, Pages 1271-1273

  Wayne, Alan S ^a   Reaman, Gregory H ^b   Helman, Lee J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE NONLYMPHOCYTIC LEUKEMIA; CANCER MORTALITY; CANCER SURVIVAL; CANCER THERAPY; DISEASE FREE SURVIVAL; EDITORIAL; HEMATOLOGIC MALIGNANCY; HIGH RISK POPULATION; HODGKIN DISEASE; INCIDENCE; MORBIDITY; NONHODGKIN LYMPHOMA; PHILADELPHIA CHROMOSOME POSITIVE CELL; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME;

CHILD; CLINICAL TRIALS AS TOPIC; DISEASE-FREE SURVIVAL; HEALTH STATUS; HEMATOLOGIC NEOPLASMS; HODGKIN DISEASE; HUMANS; LEUKEMIA, MYELOID, ACUTE; LYMPHOMA, NON-HODGKIN; MORTALITY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; QUALITY OF LIFE; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 52449108386     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djn306     Document Type: Editorial

References (10)

1. Gloeckler Ries LA, Percy CL, Bunin GR. Introduction. In: Reis LAG, Smith MA, Gurney JG, et al., eds. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995. Bethesda, MD: National Cancer Institute, SEER Program; 1999:1-16. NIH Publication No. 99-4649. http://www-seer.ims.nci.nih.gov.
2. Kersey JH. Fifty years of studies of the biology and therapy of childhood leukemia. Blood. 1997;90(11):4243-4251.
3. Pui C-H, Evans WE. Acute lymphoblastic leukemia. N Engl J Med. 1998;339(9):605-615.
4. de Botton S, Coiteux V, Chevret S, et al. Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy. J Clin Oncol. 2004;22(8):1404-1412.
5. Fuster JL, Bermúdez M, Galera A, Llinares ME, Calle D, Ortuño FJ. Imatinib mesylate in combination with chemotherapy in four children with de novo and advanced stage Philadelphia chromosome-positive acute lymphoblastic leukemia. Haematologica. 2007;92(12):1723-1724.
6. Gloeckler Ries LA. Childhood cancer mortality. In: Reis LAG, Smith MA, Gurney JG, et al., eds. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995. Bethesda, MD: National Cancer Institute, SEER Program; 1999:165-170. NIH Publication No. 99-4649. http://www-seer.ims.nci.nih.gov.
7. Oeffinger KC, Mertesn AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572- 1582.
8. Pulte D, Gondos A, Brenner H. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004. J Natl Cancer Inst. 2008;100(18):1301-1309.
9. Frost R. Stopping by Woods on a Snowy Evening. 1928; New York, NY: Henry Holt and Company.
10. Schultz KR, Bowman WP, Slayton W, et al. Improved early event free survival in children with Philadelphia chromosome-positive acute lymphoblastic leukemia with intensive imatinib in combination with high dose chemotherapy: Children's Oncology Group (COG) Study AALL0031. Blood. 2007;110(11). Abstract 4.